# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
On July 30, 2024, the Company received a letter from the listing qualifications department staff of the Nasdaq Stock Market LLC...
VBI Vaccines Inc. (NASDAQ:VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention a...
- Reuters